The Supreme Court has stayed the import of drugs from a private Indian supplier under the Indian Credit Concession (ICL) saying that serious doubts have been raised about the quality, safety and efficacy of products purchased from Savorite Pharmaceuticals (Pvt) Ltd.
The court imposed the ban while hearing a fundamental rights petition filed by Transparency International Sri Lanka (TISL) against the Health Ministry’s move to purchase drugs from two private Indian companies, Savorite Pharmaceuticals (Pvt) Ltd and Kaushik Therapeutics (P) Ltd (KTL). has.
Judge Murdu N.B. The order was issued by a three-judge bench headed by Fernando, and the other judges present were President’s Advocate Yasanta Kodagoda and President’s Advocate and Justice Achala Vengappuli.
They pointed out that there were questions about the legality of the procurement transaction.
The court granted two interim reliefs, one of which ordered that future imports of the drug from Savorite be suspended without further orders. The other prohibition was that drugs should be imported subject to court confirmation that quality and safety requirements were met and that the procurement was legal.
